You are here: Industry Insights > revenue

News List

Ping An Good Doctor's Revenue for 2019 Amounted to RMB5.065 Billion, with its Losses Continuously Narrowed and Online Medical Services Revenue Doubling by 109% over the Same Period prnasia
February 12, 2020
It revealed that Ping An Good Doctor's earnings in its business segments have maintained good growth in 2019, achieving a total revenue of RMB5.065 billion, representing a year-on-year increase of 52%.
Biocon Q1FY20 Revenue grows by 25 per cent expresspharma
July 30, 2019
Biocon has announced its consolidated financial results for the fiscal first quarter ended June 30, 2019. Commenting on the highlights, Chairperson and Managing Director, Kiran Mazumdar-Shaw stated ...
GSK Pharmaceuticals’ revenue grows at seven per cent in Q1 expresspharma
July 25, 2019
GlaxoSmithKline Pharmaceuticals has declared its financial results for the quarter ended 30th June 2019. Revenue for the quarter came in at Rs 788 crores, an increase of seven per cent over the same period last year.
The top 15 pharma companies by 2018 revenue fiercepharma
April 08, 2019
The pharma industry is always in flux, but the big names always turn up near the top of yearly?sales rankings.
Mylan reports lower than expected earnings pharmaphorum
February 28, 2019
Mylan has reported lower than expected full year earnings and 2019 forecasts, thanks partly to delays in its generic Advair approval and continuing problems at its US manufacturing plant.
Takeda hits FDA snag on Ninlaro, but its growth still helps drive revenue hike fiercepharma
February 02, 2019
In Takeda’s last quarterly report as a separate company from Shire, things seem to be going its way—key drugs are growing nicely, Shire integration is on track, and cash-raising sell-offs are underway, executives said.
GW launches cannabis-based epilepsy drug in US pharmaphorum
November 30, 2018
GW Pharmaceuticals is bullish about the company’s prospects following the launch of its cannabis-based medicine for a rare form of childhood epilepsy.
Natco Pharma posts over two-fold jump in Q2 PAT to ? 181.6 crore expressbpd
November 06, 2018
The company had posted a consolidated profit after tax of ? 84.4 crore in the same quarter
Pfizer Q3 results: growth in revenue and income led innovative health segment pharmaceutical-technology
October 31, 2018
Pfizer has reported a 1% or $130m growth in revenue for the third quarter (Q3) 2018 to $13.3bn, compared to Q3 2017.
NATCO Pharma posts consolidated total revenue of Rs 2078.9 cr for the year ended on March 31, 2017 financialexpress
June 01, 2017
In Q4, the company recorded a net revenue of Rs 577.2 crore, on a consolidated basis